Continuity builds physical intelligence for human health that continuously decodes molecular signals inside the body, interprets them in real time, and autonomously takes action to protect and enhance human life.
Modern healthcare is defined by scarcity. Care is strictly rationed because there are not enough clinicians and resources. Millions of people lack access to the care they deserve. Continuity builds autonomous systems that make personalized care and health abundant at scale.
Our interface tracks dozens of blood biomarkers in real time, directly from the body, without a blood draw.
Continuous data lets AI simulate health trajectories, responses, and outcomes at the individual level.
Interventions are delivered autonomously and adjusted in real time based on their effects.
A bioprotonics sensing array reads blood biomarkers directly and continuously. Where a lab panel captures only the time point of sampling, the array returns a curve of the levels over time.
Continuous data lets AI learn an individual's baseline and normal range, then flag deviations well before any population-based model would register an issue.
The system acts on the live data stream and intervenes in real time. Because it keeps monitoring, it can track the response and adjust continuously.
An MIT spin-off with deep expertise in molecular sensing, engineering, and data science.
Backed by leading founders and executives in health, and working with world-leading clinicians and scientists.